Detalhe da pesquisa
1.
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice.
Proc Natl Acad Sci U S A
; 118(38)2021 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34493582
2.
Minimal purification method enables developability assessment of recombinant proteins.
Biotechnol Bioeng
; 2023 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36929469
3.
Modeling the long-term 2-8 °C stability profiles of a live, rotavirus vaccine candidate (RV3-BB) in various liquid formulations via extrapolations of real-time and accelerated stability data.
Biologicals
; 75: 21-28, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34924260
4.
Crystallization of a nonreplicating rotavirus vaccine candidate.
Biotechnol Bioeng
; 118(4): 1750-1756, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33527346
5.
Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus.
Microb Cell Fact
; 20(1): 94, 2021 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33933073
6.
The Pfs230 N-terminal fragment, Pfs230D1+: expression and characterization of a potential malaria transmission-blocking vaccine candidate.
Malar J
; 18(1): 356, 2019 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31703583
7.
Empirical Correction for Differences in Chemical Exchange Rates in Hydrogen Exchange-Mass Spectrometry Measurements.
Anal Chem
; 89(17): 8931-8941, 2017 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28753295
8.
Site-Specific Hydrolysis Reaction C-Terminal of Methionine in Met-His during Metal-Catalyzed Oxidation of IgG-1.
Mol Pharm
; 13(4): 1317-28, 2016 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26942274
9.
Impact of detergent on biophysical properties and immune response of the IpaDB fusion protein, a candidate subunit vaccine against Shigella species.
Infect Immun
; 83(1): 292-9, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25368115
10.
Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies.
Biologicals
; 42(5): 237-59, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24996452
11.
Formulation Studies to Develop Low-Cost, Orally-Delivered Secretory IgA Monoclonal Antibodies for Passive Immunization Against Enterotoxigenic Escherichia coli.
J Pharm Sci
; 112(7): 1832-1844, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37040833
12.
Correlating physicochemical and biological properties to define critical quality attributes of a rAAV vaccine candidate.
Mol Ther Methods Clin Dev
; 30: 103-121, 2023 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37746246
13.
Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 spike ferritin nanoparticle vaccine antigen produced from two different cell lines.
Vaccine
; 41(44): 6502-6513, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37620203
14.
Measurement of Adenovirus-Based Vector Heterogeneity.
J Pharm Sci
; 112(4): 974-984, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36563855
15.
Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 Spike ferritin nanoparticle vaccine antigen produced from two different cell lines.
bioRxiv
; 2023 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37066156
16.
Nanoalum Formulations Containing Aluminum Hydroxide and CpG 1018TM Adjuvants: The Effect on Stability and Immunogenicity of a Recombinant SARS-CoV-2 RBD Antigen.
Vaccines (Basel)
; 11(6)2023 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37376419
17.
Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor-binding domain (RBD).
Hum Vaccin Immunother
; 19(2): 2264594, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37932241
18.
Multi-dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part II- Real-time and Accelerated Stability Studies.
J Pharm Sci
; 112(2): 458-470, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36462710
19.
Multi-Dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part I - Screening of Preservative Combinations.
J Pharm Sci
; 112(2): 446-457, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36096284
20.
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates.
Nat Commun
; 14(1): 2149, 2023 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37069151